Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis. (Q51571372)

7 April 2018

title

Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis. (English)

1 reference

7 April 2018

author name string

McLaren CE

1

1 reference

7 April 2018

McLachlan GJ

2

1 reference

7 April 2018

Halliday JW

3

1 reference

7 April 2018

Webb SI

4

1 reference

7 April 2018

Leggett BA

5

1 reference

7 April 2018

Jazwinska EC

6

1 reference

7 April 2018

Crawford DH

7

1 reference

7 April 2018

Gordeuk VR

8

1 reference

7 April 2018

McLaren GD

9

1 reference

7 April 2018

Powell LW

10

1 reference

7 April 2018

language of work or name

English

0 references

publication date

1 March 1998

1 reference

7 April 2018

published in

Gastroenterology

1 reference

7 April 2018

volume

114

1 reference

7 April 2018

issue

3

1 reference

7 April 2018

page(s)

543-549

1 reference

7 April 2018

Prevalence of hemochromatosis in Finland

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Prevalence of hereditary haemochromatosis in two Swedish urban areas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Prevalence of haemochromatosis amongst asymptomatic Australians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Prevalence of hemochromatosis in a random sample of asymptomatic men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Percent transferrin saturation in segregating hemochromatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Hereditary hemochromatosis. Analysis of laboratory expression of the disease by genotype in 18 pedigrees

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Screening for hemochromatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXXIX. THE ANEMIA OF INFECTION. STUDIES ON THE IRON-BINDING CAPACITY OF SERUM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

THE DIAGNOSIS OF IRON DEFICIENCY ANEMIA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Serum ferritin as a measure of iron stores in normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Detection of two-component mixtures of lognormal distributions in grouped, doubly truncated data: analysis of red blood cell volume distributions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Long-term survival in patients with hereditary hemochromatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Association of HLA-linked hemochromatosis with idiopathic refractory sideroblastic anemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Association of hereditary spherocytosis and idiopathic hemochromatosis. A synergistic effect in determining iron overload.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Hemochromatosis heterozygotes may have significant iron overload when they also have hereditary spherocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Iron status in red cell pyruvate kinase deficiency: study of Italian cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Heterozygosity for HLA-linked hemochromatosis as a likely cause of the hepatic siderosis associated with sporadic porphyria cutanea tarda

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Evidence for heterogeneity in hereditary hemochromatosis. Evaluation of 174 persons in nine families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Etiologies, consequences, and treatment of iron overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Clinical and biochemical abnormalities in people heterozygous for hemochromatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Mutation analysis in hereditary hemochromatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Haemochromatosis and HLA-H.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

Haemochromatosis and HLA-H

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970538-4

10.1016/S0016-5085(98)70538-4

7 January 2021

Identifiers

DOI

1 reference

7 April 2018

1 reference

7 April 2018